These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. I.v. therapy: the legislative and regulatory arena. Hughes C; Berke D Caring; 1990 May; 9(5):4-7. PubMed ID: 10106790 [TBL] [Abstract][Full Text] [Related]
5. Home intravenous drug therapy under Medicare. Leader S Pride Inst J Long Term Home Health Care; 1989; 8(3):8-14. PubMed ID: 10303820 [No Abstract] [Full Text] [Related]
6. Home iv therapy benefit of the Catastrophic Coverage Act: it's impact on home care providers. Marren J; Rodgers B; Dishon M Pride Inst J Long Term Home Health Care; 1989; 8(3):15-8. PubMed ID: 10303818 [No Abstract] [Full Text] [Related]
7. Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule. Fed Regist; 1989 Nov; 54(215):46938-53. PubMed ID: 10303985 [TBL] [Abstract][Full Text] [Related]
8. Unissued rules worry home care providers. Lutz S Mod Healthc; 1989 Sep; 19(35):34, 36. PubMed ID: 10303811 [No Abstract] [Full Text] [Related]
9. Medicare reimbursement for intravenous vancomycin at home. Weiss PJ; Poirier TC N Engl J Med; 1995 Apr; 332(15):1037. PubMed ID: 7885423 [No Abstract] [Full Text] [Related]
10. Home i.v. therapy companies target insurers, HMOs for future growth. Lutz S Mod Healthc; 1987 Mar; 17(6):96, 99. PubMed ID: 10281052 [No Abstract] [Full Text] [Related]
11. Medicare program; conditions of participation for home intravenous drug therapy providers--HCFA. Proposed rule. Fed Regist; 1989 Sep; 54(172):37220-38. PubMed ID: 10303828 [TBL] [Abstract][Full Text] [Related]
12. Home care forum: cost viewpoints. Weinstein SM NITA; 1987; 10(6):401-9. PubMed ID: 3320816 [No Abstract] [Full Text] [Related]
13. Medicare program; coverage of home intravenous drug therapy services--HCFA. Proposed rule. Fed Regist; 1989 Sep; 54(172):37422-38. PubMed ID: 10303831 [TBL] [Abstract][Full Text] [Related]
14. Overview of the Medicare Catastrophic Coverage Act of 1988 and its impact on health-care delivery. Grealy MR Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S4-9. PubMed ID: 2672805 [TBL] [Abstract][Full Text] [Related]
15. Home infusion therapy meets managed care: confrontation or cooperation. Winters RW Med Interface; 1994 Jul; 7(7):72-4, 85. PubMed ID: 10135994 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness issues for home i.v. therapy in the United States. Allen R Hosp Formul; 1993 Jan; 28 Suppl 1():37-40. PubMed ID: 10123837 [TBL] [Abstract][Full Text] [Related]
17. Bears circle Medical Care America. Lutz S Mod Healthc; 1993 Mar; 23(10):17. PubMed ID: 10124321 [No Abstract] [Full Text] [Related]
18. Homedco and Abbey among companies that have viewed T2's books. Burns J Mod Healthc; 1994 Jan; 24(5):10. PubMed ID: 10131365 [No Abstract] [Full Text] [Related]
19. The home infusion industry: patients' angel or their ruthless plunderer? Margolis RE Healthspan; 1993 Jun; 10(6):18-20. PubMed ID: 10127303 [No Abstract] [Full Text] [Related]
20. Home infusion therapy: comparison of costs for intravenous immunoglobulin. Bielory L; Long GC N J Med; 1993 Jul; 90(7):512-5. PubMed ID: 8355890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]